Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class II · Moderate risk Terminated Initiated Jul 3, 2018 (8 years ago)

Potassium Chloride For Injection Concentrate syringe 40 mEq/20 mL

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

CGMP Deviations: Syringes were filled with 19mL of potassium chloride when the labels displayed a fill of 20mL.

Cause type: Labeling / mix-up

Wrong label, wrong strength, mixed-up products, or packaging errors. One of the most dangerous causes - you can end up taking the wrong drug or the wrong dose. All labeling / mix-up recalls.

What was recalled

Potassium Chloride For Injection Concentrate syringe 40 mEq/20 mL (2 mEq/mL), Rx only, Medi-Fare Drug Pharmaceutical Compounding 300 West Pine St., Blacksburg, SC 29702 800-622-0007

Recalling firm
Medi-Fare Drug and Home Health Center
Origin
SC, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0919-2018 · FDA notice

Check, then ask. Class II means harm is possible but usually temporary or reversible. Find the lot number on your package; if it matches, ask your pharmacist about a replacement. Do not simply stop a prescribed medication on your own - the gap can be riskier than the recall. This recall is now terminated, which means the firm has finished removing the affected product; anything on pharmacy shelves today should be unaffected.

Other labeling / mix-up recalls from 2018

All labeling / mix-up recalls
Class III · Low risk

Loperamide HCL Tablets USP

Labeling Not Elsewhere Classified: The front panel indicates 24 caplets whereas the side panel indicates 12 caplets. The drug product carton contains 24 caplets.

Terminated Labeling / mix-up Sun Pharmaceutical Industries, Inc. D-0391-2019
Class I · High risk

Dyural-80 Injection Kit

Labeling: Not eslewhere classified - The kits include Sodium Chloride, USP, 0.9% which was recalled by the manufacturer due to the product insert incorrectly stating stoppers do not contain latex. The stoppers contain natural rubber latex

Terminated Labeling / mix-up Asclemed USA Inc. dba Enovachem NDC 76420-0755-01 D-0354-2019
Class I · High risk

Dyural-40 Injection Kit

Labeling: Not eslewhere classified - The kits include Sodium Chloride, USP, 0.9% which was recalled by the manufacturer due to the product insert incorrectly stating stoppers do not contain latex. The stoppers contain natural rubber latex

Terminated Labeling / mix-up Asclemed USA Inc. dba Enovachem NDC 76420-0750-01 D-0353-2019